The One Document That Makes A Supplement Checkable
Everything on the front of a bottle was chosen by a marketing department. One panel on the back was not, and it is the only part you can actually use.
The Livpure Label Blog
Longer pieces on the one document that makes a supplement checkable, what the small marks on a pack are actually for, why a photograph of a plant is not evidence that the plant is in the bottle, what a mineral with a Daily Value does and does not need a capsule for, what the berberine fatty liver trials measured, and what the ALT and AST numbers in liver studies mean. Written by the editorial desk that publishes the rest of this site.
Quick answer
The Livpure blog publishes plain-language articles on supplement labels: how blends work, what a percentage of a Daily Value does and does not mean, and why two labels printing the same number can deliver different amounts. Every post is written by the Thelivpure Editorial Desk, carries a visible last-updated date, and cites only sources we opened and read.
An Asterisk, A Dagger And A Footnote
Two symbols appear on almost every supplement in the shop. They do different jobs, they live in different places, and most people have never been told which is which.
Pictures Are Not Ingredients
A photograph of a milk thistle flower is evidence that somebody bought a stock photograph of a milk thistle flower. It is not evidence about what is in the capsule.
Molybdenum: The Mineral Almost Nobody Is Short Of
The one Livpure ingredient with an official Daily Value, no known shortage in healthy people, and no amount printed on this pack. What it does, the numbers people quote, and why they disagree.
Berberine And Fatty Liver: What The Trials Actually Measured
Three studies in fatty liver, three different things measured. Lower enzymes in two, no change in liver fat on a scan in the biggest, and the medicine interactions that sit beside them.
ALT And AST: The Numbers Behind Every Liver Supplement Study
Almost every liver supplement study reports an enzyme. What ALT and AST are, why healthy limits are lower than the printout, and why a falling number is not the same as a healthier liver.
What this blog is for
Six posts so far, and more when we have something worth adding rather than on a schedule.
A supplement panel is a legal document written to a format. Once you can read one, most of the marketing around it stops working, and that is what these posts are for. They are about labels rather than about promises, because a label is the one part of a supplement that has rules attached to it.
Each post works its example on this product rather than on somebody else's. The panel post is about a panel this product does not have. The reference-marks post is about the dagger on our own front label. The artwork post counts our own brand's ingredient photographs against its own ingredient list. The molybdenum post is about the one ingredient on our list that has a reference number, and the berberine post is about the most-studied one.
Every post carries a visible last-updated date, a byline from the editorial desk rather than an invented author, and links to the sources we actually opened. Where a study found nothing, we say so, including when the ingredient is one of ours.
What each post covers
The one document that makes a supplement checkable. What 21 CFR 101.36 actually requires on a Supplement Facts panel, what each line is for, what a reader can do with it in thirty seconds, and what is left when the panel is missing.
A dagger, an asterisk and a footnote. The three reference marks that appear on supplement packaging, what each one conventionally points at, why they are not interchangeable, and what it means when one has no destination.
Pictures are not ingredients. Why ingredient photography is the most persuasive and least regulated part of a supplement listing, how to count artwork against a declared ingredient list, and what our own brand's asset pack shows when you do it.
Molybdenum: the mineral almost nobody is short of. What the trace mineral does in four enzymes, the reference figures from the US, the EU and the Nordic countries and why they differ, the one rare inherited deficiency, and what a panel would have to print that ours does not.
Berberine and fatty liver: what the trials actually measured. A ten-trial pooled analysis, a 12-week trial and a 337-person, six-month trial set side by side, why enzymes and liver fat are different measurements, and the medicine interactions that sit next to the research.
ALT and AST: the numbers behind every liver supplement study. What the enzymes are, why healthy limits are lower than the lab printout, why placebo groups improve too, and five questions that work on any trial.
How topics get chosen
From questions that arrive at the desk. If the same thing is asked three times, it becomes a post. That is a slower schedule than most brand blogs run on, and it is the reason there are six posts here rather than thirty thin ones written to a keyword list.
Nothing on this blog is written to rank for a search term the desk does not understand. Every post is long because the subjects are, and every one of them says plainly where the evidence for our own product stops.
Every post is bylined to the editorial desk that writes the product pages, which matters because it means the person explaining that this product has no Supplement Facts panel is the same person writing the page with the buy button on it.
If there is something you want covered, email [email protected]. The posts that get written are usually the ones somebody asked for.
The rules this blog is written to
Six of them. They are checkable, which is the only kind of editorial promise worth publishing.
No post ends in a sale
Every post carries one panel about the product behind the site, placed in the middle where you can skip it, and then goes back to the subject. A post whose last paragraph is a call to action was written for the seller rather than for the reader, and this desk would rather lose that sale.
Sources are opened before they are cited
Every study named on this blog is one the desk read. Where a source found the opposite of what a supplement page would want, it is cited anyway. The NCCIH line about liver injury reported with green tea extracts is on this site precisely because it is our own ingredient.
No invented authors
Posts are bylined to the editorial desk, which is an organisation. There is no stock photograph of a doctor at the top of any page on this site, no fabricated credential and no first name without a surname.
The method is run on our own label
Every post that describes a way to check a label then applies it to this one. Using a competitor's panel as the worked example would be easier and it would be cowardly.
Dates are visible and corrections move them
Every post shows when it was published and when it was last updated. If a correction is made, the second date moves forward, which is how a reader can tell the difference between a page that has been checked and one that has simply been sitting there.
No disease claims, anywhere
Nothing on this blog says or implies that a supplement treats, prevents or reverses a condition. That includes careful phrasing designed to let a reader draw the conclusion without the sentence saying it, which is the version most supplement blogs use.
What this blog will not publish
Listicles of miracle ingredients. Every one of them is built backwards from a product page, and the ranking is decided by what the writer is selling rather than by what the trials found.
Detox and cleanse explainers. The word detox has no agreed meaning in nutrition, no measurable endpoint and no test that distinguishes a detoxified person from an ordinary one. Our own product's sales page says it supports liver detoxification, and we do not repeat that as though it meant something specific.
Personal anecdotes presented as evidence. One person feeling better for a fortnight tells you about that fortnight. It is not data and framing it as data is how this category lost most of its credibility.
Competitor comparisons. We sell one product. A table putting it above three named rivals would be a marketing asset, not an article, and no reader should trust one published by a seller.
Fear-led openings. Posts in this category often start by describing a frightening symptom and then pivot to a bottle. That sequence is effective and it is not something this desk is willing to do. If something about your health has changed in a way you or your family have noticed, the answer is an appointment, not a purchase, and we say that on the product pages as well as here.
Finally, nothing here is generated and published without being read. Every post on this blog was written, checked against its sources and read end to end before it went up, and if one of them is wrong we would rather hear it from you than leave it standing.
Who writes these posts
The same editorial desk that writes the product pages on this site. There is no separate content team, no freelance byline and no agency. That matters because it means the person writing about the limits of proprietary blends is the same person writing the page that sells one.
The desk earns when you buy, and that is disclosed in the footer of every page including this one. A blog published by a seller is never neutral, and the useful response to that is not to claim neutrality but to publish the things that cost the seller money. The dose chart on the home page, the complaints in the review section, the table telling you what to buy instead and an editorial score of 2.6 out of 5 are all on this site for that reason.
If you want to see the method in full, the about page sets out the six rules every page here is written to, along with the list of everything we were not given and the four places where our sources disagreed.
Corrections are welcome and are treated as the most valuable message this desk receives. Send the post address and one sentence about what is wrong to [email protected], and if you are correcting a citation, say which claim and which paper. Those get checked the same day.